The impact of resveratrol on toxicity and related complications of advanced glycation end products: A systematic review

Biofactors. 2019 Sep;45(5):651-665. doi: 10.1002/biof.1531. Epub 2019 Jun 11.

Abstract

Accumulation of advanced glycation end products (AGEs) promotes the generation of free radicals, which leads to chronic oxidative stress predisposing to chronic oxidative stress, inflammation, and related diseases. This systematic review aimed to determine the effect of resveratrol (RSV) on AGE-induced toxicity and its deleterious consequences. A comprehensive search was performed through literature were published until December 2018 using relevant keywords. The databases that were used for the search were PubMed, Scopus, Embase, ProQuest, and Google Scholar. A total of 29 eligible studies were found and included in the review for the analysis. Except one, all studies showed suppressing effects for RSV on the production of AGEs or receptor for advanced glycation end products (RAGE) and its detrimental consequences including oxidative stress, inflammatory response, cellular immune reactions, insulin response, and atherosclerosis. RSV exerts its effects through influencing RAGE, nuclear factor kappa B (NF-κB), peroxisome proliferator-activated receptor (PPAR) γ, and transforming growth factor (TGF)-β activities. This review suggests that RSV has got potential to decrease AGEs toxicity and inhibit the AGE-induced complications. More clinical trials are suggested to evaluate the beneficial effect of RSV on AGEs in chronic metabolic diseases.

Keywords: AGEs; antiglycation; inflammation; oxidative stress; resveratrol.

Publication types

  • Systematic Review

MeSH terms

  • Animals
  • Antigens, Neoplasm / genetics*
  • Antigens, Neoplasm / metabolism
  • Antioxidants / pharmacology*
  • Atherosclerosis / drug therapy*
  • Atherosclerosis / genetics
  • Atherosclerosis / metabolism
  • Atherosclerosis / pathology
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / genetics
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / pathology
  • Gene Expression Regulation
  • Glycation End Products, Advanced / antagonists & inhibitors
  • Glycation End Products, Advanced / genetics*
  • Glycation End Products, Advanced / metabolism
  • Glycation End Products, Advanced / toxicity
  • Humans
  • Inflammation
  • Mitogen-Activated Protein Kinases / genetics*
  • Mitogen-Activated Protein Kinases / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Oxidative Stress
  • PPAR gamma / genetics
  • PPAR gamma / metabolism
  • Pyruvaldehyde / metabolism
  • Resveratrol / pharmacology*
  • Signal Transduction
  • Transforming Growth Factor beta1 / genetics
  • Transforming Growth Factor beta1 / metabolism

Substances

  • Antigens, Neoplasm
  • Antioxidants
  • Glycation End Products, Advanced
  • NF-kappa B
  • PPAR gamma
  • PPARG protein, human
  • TGFB1 protein, human
  • Transforming Growth Factor beta1
  • Pyruvaldehyde
  • MOK protein, human
  • Mitogen-Activated Protein Kinases
  • Resveratrol